An acquirer can obtain an unfinished project as part of a business combination. That acquisition-date item and the acquirer's later laboratory payroll are not one cost pool. The transaction model, identifiability, supplied fair value, and project status control the acquired item; the later work returns to the applicable post-acquisition R&D or software guidance.
In the Linden Peak packet, the acquisition schedule separately identifies a supplied $300,000 IPR&D amount. That figure is not capitalized because the controller believes the project will succeed; it is a stipulated acquisition- date measurement inside a stipulated business combination.
The core example does not estimate fair value, completion probability, or useful life. It preserves the asset's identity so completion, abandonment, impairment, and later amortization questions cannot disappear into goodwill.
Apply the distinction
A supplied acquisition-date IPR&D asset and the acquirer's later laboratory payroll are two events. Keeping their dates separate preserves both the acquisition allocation and post-acquisition R&D performance.
Authority
Read ASC 805-20-25-1 for separate acquisition-date recognition of identifiable assets apart from goodwill.
Read ASC 730-10-15-4 for the R&D scope exception for assets acquired in a business combination.
Put the concept to work
Analyze this concept
- Separate acquired in-process R&D from the acquirer's post-acquisition internal R&D and identify which supplied transaction-scope facts control each route.
Learning resources
Choose a lesson, try an application, or inspect the sources behind this concept.
Build on these ideas
- Research and development cost — Apply
To analyze this concept: Required. The learner needs the ordinary internal R&D route to understand why acquisition scope changes the analysis.